Brenner Robert 4
4 · Vera Therapeutics, Inc. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Brenner Robert
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-03+350,000→ 350,000 totalExercise: $15.36Exp: 2034-01-02→ Class A Common Stock (350,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option vest on January 3, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.